XRTX Stock Latest News
Company AnnouncementsXORTX Moves to File Health Canada Trial Application for XRx-026 Gout Program2w ago6KXRTX
Company AnnouncementsXORTX Plans Q4 2026 FDA IND Filing for XRx-026 Gout Therapy1M ago6KXRTX
Company AnnouncementsXORTX Starts Clinical and Commercial Manufacturing of XORLO for Gout Program1M ago6KXRTXCompany AnnouncementsXORTX Re-Engages IR Firm After TSXV Delisting to Bolster Nasdaq-Focused Profile1M agoXRTX
- Company AnnouncementsXORTX Terminates IR Agreement, Postpones Marketing Amid TSXV Delisting1M ago6KXRTX
Company AnnouncementsXORTX Therapeutics Files August Form 6-K Highlighting Stronger June 2026 Balance Sheet2M ago6KXRTX
Company AnnouncementsXORTX Therapeutics Announces Resignation of Board Chairman Anthony Giovinazzo2M ago6KXRTXCompany AnnouncementsXORTX Therapeutics Adds Independent Director to Strengthen Board Oversight2M ago6KXRTX
- Company AnnouncementsXORTX Resets Strategy, Accelerates Gout Program and Names Mika Grasso Co-CEO4M ago6KXRTX
- Company AnnouncementsXORTX to Voluntarily Delist from TSX Venture Exchange, Maintain Nasdaq Listing4M ago6KXRTX
- Company AnnouncementsXORTX Raises US$5 Million in Public Offering to Fund Kidney and Gout Drug Programs5M ago6KXRTX
- Company AnnouncementsXORTX files Q1 2026 unaudited results showing lower cash and equity5M ago6KXRTX
Company AnnouncementsXORTX Therapeutics Prices US$5 Million Public Offering to Fund Late-Stage Kidney and Gout Pipeline5M ago6KXRTX